James V Cassella insider trades: Concert Pharmaceuticals (CNCE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
13 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 15, 2023 | CNCE | ↓ Sell | 3,762 | $8.34 | $31K | Direct | Feb 16, 2023 (1d) |
| Jan 30, 2023 | CNCE | ↓ Sell | 10,106 | $8.35 | $84K | Direct | Jan 31, 2023 (1d) |
| Jan 6, 2023 | CNCE | ↓ Sell | 2,893 | $7.25 | $21K | Direct | Jan 9, 2023 (3d) |
| Feb 14, 2022 | CNCE | ↓ Sell | 3,762 | $3.09 | $12K | Direct | Feb 16, 2022 (2d) |
| Jan 5, 2022 | CNCE | ↓ Sell | 2,894 | $3.19 | $9K | Direct | Jan 7, 2022 (2d) |
| Aug 16, 2021 | CNCE | ↓ Sell | 8,086 | $3.28 | $27K | Direct | Aug 17, 2021 (1d) |
| Feb 16, 2021 | CNCE | ↓ Sell | 3,763 | $7.32 | $28K | Direct | Feb 17, 2021 (1d) |
| Aug 17, 2020 | CNCE | ↓ Sell | 4,354 | $10.37 | $45K | Direct | Aug 19, 2020 (2d) |
| Apr 17, 2018 | CNCE | ↓ Sell | 10,582 | $20.18 | $214K | Direct | Apr 19, 2018 (2d) |
| Dec 26, 2012 | ALXA | ↓ Sell10b5-1 | 4,558 | $4.90 | $22K | Direct | Dec 27, 2012 (1d) |
| Aug 27, 2012 | ALXA | ↓ Sell10b5-1 | 10,000 | $4.14 | $41K | Direct | Aug 29, 2012 (2d) |
| Jun 6, 2012 | ALXA | ↓ Sell10b5-1 | 46,222 | $0.34 | $16K | Direct | Jun 8, 2012 (2d) |
| Dec 18, 2009 | ALXA | ↓ Sell | 24,424 | $2.23 | $54K | Direct | Dec 18, 2009 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About James V Cassella's insider trades
James V Cassella is Chief Development Officer at Concert Pharmaceuticals (CNCE). Since Dec 18, 2009, James has reported no open-market purchases and 13 sales worth $604K on SEC Form 4. There have been no open-market trades in the last 12 months.
3 sales (13% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (36 filings), shares returned to the company (2 filings), other transactions (2 filings), shares withheld for taxes (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CNCE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.